GDF15 is a transforming growth factor- β (TGF-β) superfamily member that has recently generated broad interest as a new target to develop pharmacotherapies for obesity and related comorbidities. This evidence concerns the gene GDF15 and obesity due to melanocortin 4 receptor deficiency.